Cannabidiol (CBD) has long been marketed for wellness, but could it someday help prevent HIV transmission?
A preliminary study published in Mucosal Immunology examined whether CBD affected HIV-1 transfer between cells, direct infection of certain immune cells, and early tissue-level responses linked to transmission.
RELATED: These cannabis compounds have an unexpected impact on liver health
HIV can enter mucosal tissues during sex and interact with immune cells near the tissue surface. The researchers focused on cell types involved in early HIV transmission, including Langerhans cells, dendritic cells, macrophages, and certain T-cells.
Using immune-cell lab models, the researchers tested CBD alongside an endocannabinoid called AEA. They also used ex vivo human inner foreskin tissue, meaning tissue studied outside the body in a controlled lab setting.
The researchers found that CBD reduced HIV transfer from Langerhans-like cells and dendritic cells to CD4+ T-cells, while also limiting direct infection. In the inner foreskin tissue, CBD increased the secretion of an anti-HIV molecule and reduced cell infection after HIV exposure.
But why is this? The researchers said CBD may activate a cellular pathway involving TRPV1, a receptor that senses certain stimuli. In turn, the receptor may influence immune-cell behavior in ways that could reduce HIV transmission.
RELATED: CHS: What to know about the rare cannabis condition
Previous research has also suggested cannabinoids may influence viral replication, immune signaling, and inflammatory responses tied to HIV infection, though clinical evidence in humans remains limited.
While CBD showed promise in these models, the research remains in an early stage. The findings do not show that CBD prevents HIV in humans. Instead, they suggest potential antiviral effects that require further study to determine whether the lab results could translate safely and effectively to people.
While PrEP is already a popular prescription medication proven to reduce the risk of HIV transmission, the study authors proposed the idea of a future “CBD PrEP” approach, in which CBD-containing topical products could be studied for HIV prevention. However, the concept remains hypothetical and requires substantially more research.